Activation of the gene for the PDGF receptor β (PDGFRβ) in interleukin-3-dependent myeloid cells by retroviral insertional mutagenesis: Implications for the transforming potential of PDGFRβ

Growth Factors

Volumn 20, Issue 3, 2002, Pages 131-140

  Meyer, Johann ^a   Laker, Christine ^a   Janzir, Nadia ^a   Franz, Marie Joseé ^a   Bergholz, Ursula ^a   Ostertag, Wolfram ^a   Stocking, Carol ^a  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

Factor independence; Platelet derived growth factor receptor; Retroviral insertional mutagenesis; Tel PDGFR

Indexed keywords

HYBRID PROTEIN; INTERLEUKIN 3; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; RETROVIRUS VECTOR;

ANIMAL CELL; BONE MARROW CELL; CELL GROWTH; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 5; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE OVEREXPRESSION; GENETIC CODE; HEMATOPOIESIS; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MITOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION; VIRUS DNA CELL DNA INTERACTION;

3T3 CELLS; ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, SOUTHERN; BLOTTING, WESTERN; CELL DIVISION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; INTERLEUKIN-3; MACROPHAGE COLONY-STIMULATING FACTOR; MICE; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; MUTAGENESIS; MUTATION; PROTEIN ISOFORMS; RECEPTOR, PLATELET-DERIVED GROWTH FACTOR BETA; RECOMBINANT FUSION PROTEINS; RETROVIRIDAE; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSLOCATION, GENETIC; TUMOR CELLS, CULTURED;

ANIMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0036763011     PISSN: 08977194     EISSN: None     Source Type: Journal    
DOI: 10.1080/0897719021000058139     Document Type: Review

References (43)

1. Abe, A., Emi, N., Tanimoto, M., Terasaki, H., Marunouchi, T. and Saito, H. (1997) "Fusion ofthe platelet-derived growth factor receptor β to a novel gene CEV14 in acute myelogenous leukemia after clonal evolution", Blood 90, 4271-4277.
2. Ballagi, A., Ishizaki, A., Nehlin, J.-O. and Funa, K. (1995) "Isolation and characterization of the mouse PDGF β-receptor promoter", Biochem. Biophys. Res. Commun. 210, 165-173.
3. Baum, C., Hegewisch-Becker, S., Eckert, H.-G., Stocking, C. and Ostertag, W. (1995) "Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells", J Virol. 69, 7541-7547.
4. Baum, C., Eckert, H.-G., Stocking, C. and Ostertag, W. (1996) "Activity of Friend mink cell focus-forming retroviruses during myeloerythroid hematopoiesis", Exp. Hematol. 24, 364-370.
5. Carroll, M., Thomasson, M., Barker, G., Golub, T. and Gilliland, D. (1996) "The TEL-PDGFβR fusion protein dimerizes and transforms hematopoietic cells through activation of PDGFβR dependent signaling pathways", Proc. Natl Acad Sci. USA 93, 14845.
6. Escobedo, J., Barr, P. and Williams, L. (1988) "Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor", Mol. Cell Biol. 8, 126-131.
7. Felsher, D. and Bishop, J. (1999) "Reversible tumorigenesis by MYC in hematopoietic lineages", Mol. Cell 4, 199-207.
8. Flubacher, M.M., Bear, S.E. and Tsichlis, P.N. (1994) "Replacement of interleukin-2 (IL-2)-generated mitogenic signals by a mink cell focus-forming (MCF) or xenotropic virus-induced IL-9-dependent autocrine loop: implications for MCF virus-induced leukemogenesis", J. Virol. 68, 7709-7716.
9. Gari, M., Goodeve, A., Wilson, G., Winship, P., Langabeer, S., Lynch, D., Vandenberghe, E., Peake, I. and Reilly, J. (1999) "c-kit proto-oncogene exon 8 in-frame deletion plus insertion mutations in acute myeloid leukaemia", Br J. Hematol. 105, 894-900.
10. Glover, H., Baker, D., Celetti, A. and Dibb, N. (1995) "Selection of activating mutations of c-fms in FDC-P1 cells", Oncogene 11, 1347-1356.
11. Golub, T., Barker, G., Lovett, M. and Gilliland, D. (1994) "Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation", Cell 77, 307-316.
12. Habets, G.G.M., Scholtes, E.H.M., Zudygeest, D., van der Kamen, R., Stam, J.C., Berns, A. and Collard, J.G. (1994) "Identification of an invasion-inducing gene, Tiam-1, that encodes a protein with homology to GDP-GTP exchangers for rho-like proteins", Cell 77, 537-549.
13. c-subunit", Mol. Cell Biol. 15, 2402-2412.
14. Heberlein, C., Kawai, M., Franz, M.-J., Beck-Engeser, G., Daniel, P., Ostertag, W. and Stocking, C. (1990) "Retrotransposons as mutagens in the induction of growth autonomy in hematopoietic cells", Oncogene 5, 1799-1807.
15. Herren, B., Rooney, B., Weyer, K., Iberg, N., Schmid, G. and Pech, M. (1993) "Dimerization of extracellular domains of platelet-derived growth factor receptors", J. Biol. Chem. 268, 15088-15095.
16. Hirota, S., Nishida, T., Isozaki, K., Taniguchi, M., Nakamura, J., Okazaki, T. and Kitamura, Y. (2001) "Gain-of-function mutation at the extracellular domain of KIT in gastrointestinal stromal tumours", J. Pathol. 193, 505-510.
17. Horn, S., Meyer, J., Stocking, C., Ostertag, W. and Jücker, M. (2002) "Overexpression and constitutive activation of endogenous p60c-Src in several factor-independent mutants of a GM-CSF-dependent leukemia cell line (TF-1)", Oncogene, submitted for publication.
18. Jonkers, J. and Berns, A. (1996) "Retroviral insertional mutagenesis as a strategy to identify cancer genes", Biochim. Biophys. Acta 1287, 29-57.
19. Jousset, C., Carron, C., Bourex, A., Tran Quang, C., Oury, C., Dusanter-Fourt, I., Charon, M., Levin, J., Bernard, O. and Ghysdael, J. (1997) "A domain of TEL conserved in a subset of ETS proteins defines a specific oligermization interface essential to the mitogenic properties of the TEL-PDGFRP oncoprotein", EMBO J. 16, 69-82.
20. Jücker, M., Schiffer, C. and Feldman, R. (1997) "A tyrosine-phosphorylated protein of 140 kD is constitutively associated with the phosphotyrosine binding domain of Shc and the SH3 domains of Grb2 in acute myeloid leukemia cells", Blood 89, 2024-2035.
21. Just, U., Spooncer, E., Löhler, J., Stocking, C., Ostertag, W. and Dexter, T.M. (1994) "Mutants of a multipotent hematopoietic cell line blocked in GM-CSF-induced differentiation are leukemogenic in vivo", Exp. Hematol. 22, 933-940.
22. Karasuyama, H., Rolink, A. and Melchers, F. (1988) "Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B cell blasts", J. Exp. Med. 167, 1377-1390.
23. Kato, J.-Y., Roussel, M., Ashmun, R. and Sherr, C. (1989) "Transduction of human colony-stimulating factor-1 (CSF-1) receptor into interleukin-3-dependent mouse myeloid cells induces both CSF-1-dependent and factor-independent growth", Mol. Cell Biol. 9, 4069-4073.
24. Kung, H.J., Boerkoel, C. and Carter, T.H. (1991) "Retroviral mutagenesis of cellular oncogenes: a review with insights into the mechanism of insertional activation", Curr. Top. Microbiol. Immunol. 171, 1-25.
25. von Laer, D., Thomsen, S., Vogt, B., Donath, M., Kruppa, J., Rein, A., Ostertag, W. and Stocking, C. (1998) "Entry of amphotropic and 10A1 pseudotyped murine retroviruses is restricted in hematopoietic stem cell lines", J. Virol. 72, 1424-1430.
26. Laker, C., Stocking, C., Bergholz, U., Hess, N., DeLamarter, J.F. and Ostertag, W. (1987) "Autocrine stimulation after transfer of the granulocyte/macrophage colony-stimulating factor gene and autonomous growth are distinct but interdependent steps in the oncogenic pathway", Proc. Natl Acad. Sci. USA 84, 8454 - 8462.
27. Laker, C., Friel, J., Franz, M.-J., Hara, T., Papadopoulos, P., Ostertag, W. and Stocking, C. (2000) "Transcriptional activation of the granulocyte-macrophage colony-stimulating factor receptor gene in cell mutants", Exp. Cell Res. 259, 1-11.
28. Li, J., Shen, H., Himmel, K., Dupuy, A., Largaespada, D., Nakamura, T., Shaughnessy, Jr. J., Jenkins, N. and Copeland, N. (1999) "Leukaemia disease genes: large-scale cloning and pathway predictions", Nat. Genet. 23, 253-254.
29. Look, A. (1997) "Oncogenic transcription factors in the human acute leukemias", Science 278, 1059-1064.
30. Mori, S., Heldin, C.-H. and Claesson-Welsh, L. (1993) "Ligand-induced ubiquitination of the platelet-derived growth factor β-receptor plays a negative regulatory role in its mitogenic signaling", J. Biol. Chem. 268, 577-583.
31. Mori, S., Tanaka, K., Omura, S. and Saito, Y. (1995) "Degradation process of ligand-stimulated platelet-derived factor β-receptor involves ubiquifin-proeasome proteolytic pathway", J. Biol. Chem. 270, 29447-29452.
32. Park, S., Yamashita, H., Rui, H. and Waxman, D. (2001) "Serine phosphorylation of GH-activated signal transducer and activator of transcription 5a (STAT5a) and STAT5b: impact on STAT5 transcriptional activity", Mol. Endocrinol. 15, 2157-2171.
33. Prassolov, V., Meyer, J., Brandenburg, G., Hannemann, J., Bergemann, J., Ostertag, W. and Stocking, C. (2001) "Functional identification of secondary mutations inducing autonomous growth in synergy with a truncated interleukin-3 receptor: implications for multi-step oncogenesis", Exp. Hematol. 29, 756-765.
34. Reith, A., Ellis, C., Lyman, S., Anderson, D., Williams, D., Bernstein, A. and Pawson, T. (1991) "Signal transduction by normal isoforms and W mutant variants of the Kit receptor tyrosine kinase", EMBO J. 10, 2451-2459.
35. Rhoades, K., Hetherington, C., Harakawa, N., Yergeau, D., Zhou, L., Liu, L.-Q., Little, M.-T., Tenen, D. and Zhang, D.-E. (2000) "Analysis of the role of AML1-ETO in leukemogenesis, using an inducible transgenic mouse model", Blood 96, 2108-2115.
36. Ross, T., Bernard, O., Berger, R. and Gilliland, D. (1998) "Fusion of Huntingin interacting protein 1 to platelet-derived growth factor β receptor (PDGFβR) in chronic myelomonocytic leukemia with t(5;7)(q33;q11.2)", Blood 91, 4419-4426.
37. Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J., Williams, I., Lee, C.-K., Gerthner, R., Kitamura, T., Franstve, J., Anastasiadou, E., Loh, M., Levy, D., Ilhe, J. and Gilliland, D. (2000) "Stat5a/b is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2", Mol. Cell Biol. 6, 693 -704.
38. Silvers, J. and Keerikatte, V. (1989) "Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus", J. Virol. 63, 1924-1928.
39. Sjöblom, T., Boureux, A., Rönstrand, L., Heldin, C.-H., Ghysdael, J. and Östman, A. (1999) "Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein", Oncogene 18, 7055-7062.
40. Stocking, C., Löliger, C., Kawai, M., Suciu, S., Gough, N. and Ostertag, W. (1988) "Identification of genes involved in growth autonomy of hematopoietic cells by analysis of factor independent mutants", Cell 53, 869-879.
41. Stocking, C., Bergholz, U., Friel, J., Klingler, K., Wagner, T., Starke, C., Kitamura, T., Miyajima, A. and Ostertag, W. (1993) "Distinct classes of factor-independent mutants can be isolated after retroviral mutagenesis of a human myeloid stem cell line", Growth Factors 8, 197-209.
42. Thomas, J., Leverrier, Y. and Marvel, J. (1998) "Bcl-x is the major pleiotropic antiapoptotic gene activated by retroviral insertion mutagenesis in an IL-3 dependent bone marrow derived cell line", Oncogene 16, 1399-1407.
43. Tomasson, M., Sternberg, D., Williams, I., Carroll, M., Cain, D., Aster, J., Ilaria, Jr., R., Van Etten, R. and Gilliland, D. (2000) "Fatal myeloproliferation, induced in mice by TEL/PDGFβR expression, depends on PDGFβR tyrosine 579/581", J. Clin.